{"id":"https://openalex.org/W2158476385","doi":null,"title":"Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.","display_name":"Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.","publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W2158476385","mag":"2158476385","pmid":"https://pubmed.ncbi.nlm.nih.gov/11847047","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7975269"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7975269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7975269","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AJNR Am J Neuroradiol","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7975269","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016425494","display_name":"Liesbeth Reneman","orcid":"https://orcid.org/0000-0002-5912-9971","observed_orcids":["https://orcid.org/0000-0002-5912-9971"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Liesbeth Reneman","raw_affiliation_strings":["Academic Medical Center, Department of Nuclear Medicine F2-210, Graduate School of Neurosciences, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Medical Center, Department of Nuclear Medicine F2-210, Graduate School of Neurosciences, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024309954","display_name":"Charles B.L.M. Majoie","orcid":"https://orcid.org/0000-0002-7600-9568","observed_orcids":["https://orcid.org/0000-0002-7600-9568"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles B L M Majoie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042964368","display_name":"Herman Flick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herman Flick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054111926","display_name":"Gerard J. den Heeten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerard J den Heeten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.5829,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.96621479,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"2","first_page":"231","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.021700000390410423,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10378","display_name":"Advanced MRI Techniques and Applications","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.7620000243186951},{"id":"https://openalex.org/keywords/ecstasy","display_name":"ecstasy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/n-acetylaspartate","display_name":"N-acetylaspartate","score":0.9160000085830688},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.8519999980926514},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.7979999780654907},{"id":"https://openalex.org/keywords/neuronal-loss","display_name":"neuronal loss","score":0.5389999747276306},{"id":"https://openalex.org/keywords/creatine","display_name":"creatine","score":0.49900001287460327},{"id":"https://openalex.org/keywords/choline","display_name":"choline","score":0.9909999966621399},{"id":"https://openalex.org/keywords/myo-inositol","display_name":"myo-inositol","score":0.9850000143051147},{"id":"https://openalex.org/keywords/brain-metabolite-ratios","display_name":"brain metabolite ratios","score":0.6869999766349792},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.781000018119812},{"id":"https://openalex.org/keywords/serotonergic-neurons","display_name":"serotonergic neurons","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.9435235261917114},{"id":"https://openalex.org/C2779488553","wikidata":"https://www.wikidata.org/wiki/Q625143","display_name":"Ecstasy","level":2,"score":0.8218724131584167},{"id":"https://openalex.org/C2781192897","wikidata":"https://www.wikidata.org/wiki/Q822050","display_name":"White matter","level":3,"score":0.6327977180480957},{"id":"https://openalex.org/C2779896295","wikidata":"https://www.wikidata.org/wiki/Q223600","display_name":"Creatine","level":2,"score":0.6033764481544495},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4838606119155884},{"id":"https://openalex.org/C2781123555","wikidata":"https://www.wikidata.org/wiki/Q193166","display_name":"Choline","level":2,"score":0.4560319483280182},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.44570884108543396},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.4376908838748932},{"id":"https://openalex.org/C2983163835","wikidata":"https://www.wikidata.org/wiki/Q749520","display_name":"Frontal cortex","level":2,"score":0.4155324101448059},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3936674892902374},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24314647912979126},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.21814566850662231},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.09797534346580505},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002794","descriptor_name":"Choline","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003401","descriptor_name":"Creatine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009778","descriptor_name":"Occipital Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010296","descriptor_name":"Parietal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010487","descriptor_name":"Periaqueductal Gray","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":5,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:7975269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7975269","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AJNR Am J Neuroradiol","raw_type":"Text"},{"id":"pmid:11847047","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11847047","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AJNR. American journal of neuroradiology","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/3216098c-6a4c-4a66-b3f5-4ae4bfb07b54","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/reduced-nacetylaspartate-levels-in-the-frontal-cortex-of-34methylenedioxymethamphetamine-ecstasy-users-preliminary-results(3216098c-6a4c-4a66-b3f5-4ae4bfb07b54).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AJNR. American journal of neuroradiology, 23(2), 231 - 237. American Society of Neuroradiology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/c93a0c44-dc05-4fc4-8592-6b833247dd9a","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/c93a0c44-dc05-4fc4-8592-6b833247dd9a","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Reneman, L, Majoie, C B L M, Flick, H & den Heeten, G J 2002, 'Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results', AJNR. American journal of neuroradiology, vol. 23, no. 2, pp. 231-237.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2158476385","doi":null,"is_oa":false,"landing_page_url":"http://www.ajnr.org/content/23/2/231.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S101278519","display_name":"American Journal of Neuroradiology","issn_l":"0195-6108","issn":["0195-6108","1936-959X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316165","host_organization_name":"American Society of Neuroradiology","host_organization_lineage":["https://openalex.org/P4310316165"],"host_organization_lineage_names":["American Society of Neuroradiology"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Neuroradiology","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7975269","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7975269","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AJNR Am J Neuroradiol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W142904987","https://openalex.org/W1693348571","https://openalex.org/W1745420251","https://openalex.org/W1917890358","https://openalex.org/W1949070403","https://openalex.org/W1960526592","https://openalex.org/W1968381353","https://openalex.org/W1984066695","https://openalex.org/W2006772874","https://openalex.org/W2012431780","https://openalex.org/W2012979366","https://openalex.org/W2021041549","https://openalex.org/W2026035034","https://openalex.org/W2036111662","https://openalex.org/W2037236090","https://openalex.org/W2041535807","https://openalex.org/W2049362778","https://openalex.org/W2050219143","https://openalex.org/W2058027749","https://openalex.org/W2059192721","https://openalex.org/W2059491341","https://openalex.org/W2068037088","https://openalex.org/W2069885465","https://openalex.org/W2075547235","https://openalex.org/W2081908636","https://openalex.org/W2083865676","https://openalex.org/W2101367564","https://openalex.org/W2105759389","https://openalex.org/W2106287416","https://openalex.org/W2115290225","https://openalex.org/W2121293427","https://openalex.org/W2122215269","https://openalex.org/W2126283685","https://openalex.org/W2126428553","https://openalex.org/W2139273914","https://openalex.org/W2143122654","https://openalex.org/W2146745496","https://openalex.org/W2155650035","https://openalex.org/W2155890773","https://openalex.org/W2156307345","https://openalex.org/W2171847604","https://openalex.org/W2418653515","https://openalex.org/W2437289999"],"related_works":["https://openalex.org/W2058065177","https://openalex.org/W1969046478","https://openalex.org/W2156307345","https://openalex.org/W2051863901","https://openalex.org/W2122215269","https://openalex.org/W2036754846","https://openalex.org/W1980607648","https://openalex.org/W2012979366","https://openalex.org/W2055416098","https://openalex.org/W1968869404"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"PURPOSE:":[2],"The":[3],"perceived":[4],"safety":[5],"of":[6,41,122,146,174,217,226],"the":[7,39,44,143,214,224],"recreational":[8],"drug":[9],"methylenedioxymethamphetamine":[10],"(MDMA),":[11],"or":[12,138,187],"Ecstasy,":[13],"conflicts":[14],"with":[15,58,117,135,223],"animal":[16],"evidence":[17,209],"indicating":[18],"that":[19,232],"MDMA":[20,42,67,147,176,218,227,233],"damages":[21],"cortical":[22,180],"serotonin":[23],"(5-HT)":[24],"neurons":[25],"at":[26,204],"doses":[27],"similar":[28],"to":[29,51],"those":[30],"used":[31],"by":[32],"humans.":[33],"Few":[34],"data":[35,230],"are":[36,221],"available":[37],"about":[38],"effects":[40],"on":[43],"human":[45],"brain.":[46],"This":[47],"study":[48],"was":[49],"designed":[50],"evaluate":[52],"MDMA-related":[53],"alterations":[54],"in":[55,102,142,163,213,238,243],"metabolite":[56],"ratios":[57,99,157,194,203],"single-voxel":[59,87],"proton":[60],"((1)H)":[61],"MR":[62,89,206],"spectroscopy.":[63,90],"METHODS:":[64],"Fifteen":[65],"male":[66],"users":[68],"(mean":[69],"lifetime":[70],"exposure,":[71],"723":[72],"tablets;":[73],"mean":[74],"time":[75],"since":[76],"last":[77],"tablet,":[78],"12.0":[79],"weeks)":[80],"and":[81,96,109,128,167,178,201],"12":[82],"age-matched":[83],"control":[84],"subjects":[85],"underwent":[86],"(1)H":[88,205],"N-Acetylaspartate":[91],"(NAA)/creatine":[92],"(Cr),":[93],"NAA/Choline":[94],"(Cho),":[95],"myoinositol":[97],"(MI)/Cr":[98],"were":[100,115,140,158,195],"measured":[101],"midfrontal":[103],"gray":[104,107,165],"matter,":[105,108],"midoccipital":[106],"right":[110],"parietal":[111,168],"white":[112,169],"matter.":[113],"Data":[114],"analyzed":[116],"linear":[118],"model-based":[119],"multivariate":[120],"analysis":[121],"variance.":[123],"RESULTS:":[124],"NAA/Cr":[125,150,181,200],"(P":[126,130,151,155,171],"=.04)":[127],"NAA/Cho":[129,154,188,202],"=.03)":[131],"ratios,":[132],"markers":[133],"associated":[134],"neuronal":[136,211],"loss":[137],"dysfunction,":[139],"reduced":[141],"frontal":[144,179,215],"cortex":[145,216],"users.":[148],"Neither":[149],"=.72)":[152],"nor":[153],"=.12)":[156],"different":[159],"between":[160],"both":[161],"groups":[162],"occipital":[164],"matter":[166,170],"=.18).":[172],"Extent":[173],"previous":[175],"use":[177],"(rho":[182,189],"=":[183,190],"-.50,":[184],"P":[185,192],"=.012)":[186],"-.550,":[191],"<.01)":[193],"significantly":[196],"associated.":[197],"CONCLUSION:":[198],"Reduced":[199],"spectroscopy":[207],"provide":[208],"for":[210],"abnormality":[212],"users;":[219],"these":[220],"correlated":[222],"degree":[225],"exposure.":[228],"These":[229],"suggest":[231],"may":[234],"be":[235],"a":[236],"neurotoxin":[237],"humans,":[239],"as":[240],"it":[241],"is":[242],"animals.":[244]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}